Stay updated on Gebasaxturev Combo in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Gebasaxturev Combo in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gebasaxturev Combo in Melanoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Added Revision: v3.5.4 to the Record History and removed Revision: v3.5.3, signaling an updated version entry in the study's history.
    Difference
    0.0%
    Check dated 2026-05-15T05:19:29.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A new study record revision, v3.5.3, was added to the history, and the previous revision v3.5.2 was removed from the current version list.
    Difference
    0.0%
    Check dated 2026-04-30T19:01:04.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added as the latest version, replacing v3.5.0 in the history.
    Difference
    0.0%
    Check dated 2026-04-16T11:57:16.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added to the Record History page and Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T21:23:46.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision history updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T17:52:44.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history; removed the funding-lapse notice and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T06:21:23.000Z thumbnail image

Stay in the know with updates to Gebasaxturev Combo in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gebasaxturev Combo in Melanoma Clinical Trial page.